SCYNEXIS logo
SCYNEXIS
SCYX | NASDAQ
Chart Builder DCF Calculator
$2.91
-$0.30 (-9.35%)
At close: Nov 16, 2026, 4:00 PM ET
$2.90
-$0.01 (-0.34%)
After-hours: Nov 16, 2026, 7:30 PM ET

SCYNEXIS Company Profile

Company profile explained

Company Profile

SCYNEXIS, Inc. is a biotechnology company, which engages in the development of novel oral and intravenous triterpenoid antifungal for the treatment of several fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. The company was founded by Scot Kevin Huber, Terry Eugene Marquardt, Pierre Bernard Jacques Monnet, Russell J. Outcalt, and Yves Joseph Ribeill on November 4, 1999 and is headquartered in Jersey City, NJ.

Key Executives

Name Position
David Gonzalez Angulo Chief Executive Officer, President & Director
Sanjay S. Subramanian Chief Financial Officer
Scott Sukenick Chief Legal Officer & Corporate Secretary
Daniella Gigante Vice President of Human Resources & Information Technology
Ivor Macleod Executive Officer
Todd Minga Senior Vice President of Research & Development

Latest SEC Filings

Date Type Title
Sep 28, 2026 8-K Current Report
Sep 22, 2026 4 Filing
Sep 22, 2026 3 Filing
Sep 22, 2026 8-K Current Report
Sep 11, 2026 4 Filing
Sep 11, 2026 3 Filing
Sep 10, 2026 8-K Current Report
Aug 14, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Aug 14, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Aug 12, 2026 SC 13G Statement of acquisition of beneficial ownership b...
View All SEC Filings ➞
SCYNEXIS
SCYNEXIS logo
Country United States
IPO Date May 2, 2014
Industry Medical - Pharmaceuticals
Sector Healthcare
Employees 18
CEO David Angulo

Contact Details

1 Evertrust Plaza Jersey City, New Jersey 07302-6548 United States

Stock Details

Ticker Symbol SCYX
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001178253
CUSIP Number 811292309
ISIN Number US8112923094
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.